Confrontation with Acinetobacter Baumannii by Exploiting its Biofilm: An Insight to Vaccine Development

Author(s):
Yaser FattahianYaser Fattahian1, Iraj RasooliIraj Rasooli1,*, Seyed Latif Mousavi GargariSeyed Latif Mousavi Gargari1, Gunnar SandstrmGunnar Sandstrm2, Mohammad Reza RahbarMohammad Reza Rahbar3, Jafar AmaniJafar Amani4, Shakiba Darvish Alipour AstanehShakiba Darvish Alipour Astaneh1
1Department of Biology, Shahed University, Tehran, IR Iran
2Karolinska Institutet and Karolinska, University Hospital, Huddinge, Department of Laboratory Medicine, Division of Clinical Microbiology, Stockholm, Sweden
3Molecular Diagnosis Department, Saadati Pathobiology Laboratory, Shiraz, IR Iran
4Applied Biotechnology Research Center, Baqiyatallah Medical Science University, Tehran, IR Iran
*Corresponding Author: Department of Biology, Shahed University, Tehran, IR Iran Email:

Archives of Clinical Infectious Diseases:Vol. 7, issue 1
Published online:Jan 31, 2012
Article type:Research Article
How to Cite:Fattahian Y, Rasooli I, Mousavi Gargari SL, Sandstrm G, Rahbar MR, et al. Confrontation with Acinetobacter Baumannii by Exploiting its Biofilm: An Insight to Vaccine Development. Arch Clin Infect Dis. 2012;7(1):. doi:

Abstract

Objectives:

Acinetobacter baumannii is an opportunistic pathogen that causes serious infections in humans by colonization of medical devices. The capacity of this pathogen to persist in hospital settings could be due to its ability to form biofilms. In the present study we evaluated the effect of antibodies against one of surface components of A. baumannii on in vitro biofilm formation.

Materials and Methods:

The 1113 bp fragment of Bap (biofilm associate protein)gene from A. baumannii genome was amplified and cloned. The recombinant protein was expressed and purified and used to raise antibodies in mice. Antibody titer was evaluated by ELISA. In vitro biofilm inhibition was evaluated using the mice sera.

Results:

Injection of Bap subunit resulted in high titers of antibody. Immunized mice serum had significant (P< 0.001) inhibitory effect on biofilm formation. In vitro inhibition of biofilm formation by A. baumannii was studied at 1:50 concentrations of immunized and unimmunized mice sera. Immunized mice serum had significant (P <0.001) inhibitory effect on biofilm formation.

Conclusions:

Adsorption of antibodies to Bap might interfere with bacterial adhesion to the surface. These antibodies were found to be potent biofilm inhibitors.

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Jun
2018
Acinetobacter baumannii, Alamy

Phenotypic and Genotypic Investigation of Biofilm Formation in Clinical and Environmental Isolates of Acinetobacter baumannii

Ehsan Ghasemi,
Zohreh Ghalavand,
Hossein Goudarzi,
Farshid Yeganeh,
Ali Hashemi,
Hossein Dabiri
,et al.

Ghasemi E, Ghalavand Z, Goudarzi H, Yeganeh F, Hashemi A, et al. Phenotypic and Genotypic Investigation of Biofilm Formation in Clinical and Environmental Isolates of Acinetobacter baumannii. Arch Clin Infect Dis. 2018;13(4):e12914. doi: https://doi.org/10.5812/archcid.12914

27
Jun
2018
https://www.biocote.com/blog/five-facts-acinetobacter-baumannii/

Correlation of Virulence Factors and Cell Adhesion of Clinical Isolates of Acinetobacter baumannii

Maryam Afshar Payam,
Iraj Rasooli,
Parviz Owlia,
Daryush Talei,
Shakiba Darvish Alipour Astaneh,
Shahram Nazarian

Afshar Payam M, Rasooli I, Owlia P, Talei D, Darvish Alipour Astaneh S, et al. Correlation of Virulence Factors and Cell Adhesion of Clinical Isolates of Acinetobacter baumannii. Arch Clin Infect Dis. 2018;13(3):e62841. doi: https://doi.org/10.5812/archcid.62841

1
Jan
2014

Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran

Ahya Abdi-Ali,
Saghar Hendiani,
Parisa Mohammadi,
Sara Gharavi

Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran. Jundishapur J Microbiol. 2014;7(1):e8606. doi: https://doi.org/10.5812/jjm.8606

23
Apr
2019
85766

Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran

Ahad Mahmoudi Monfared,
Aliakbar Rezaei,
Farkhondeh Poursina,
Jamshid Faghri

Mahmoudi Monfared A, Rezaei A, Poursina F, Faghri J. Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran. Arch Clin Infect Dis. 2019;14(2):e85766. doi: https://doi.org/10.5812/archcid.85766

18
Dec
2021
Trends in Med Sci

Insights into Background of Microbial Aggregations (Acinetobacter baumannii): A Century of Challenges

Nafiseh Hosseinzadeh Shakib,
Mohammad Motamedifar,
Yeganeh Sadeghi Asl

Shakib NH, Motamedifar M, Sadeghi Asl Y. Insights into Background of Microbial Aggregations (Acinetobacter baumannii): A Century of Challenges. J Adv Immunopharmacol. 2021;1(4):e119665. doi: https://doi.org/10.5812/tms.119665

Download PDF289.47 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles